Venneos Overview

  • Founded
  • 2014

  • Status
  • Out of Business

  • Employees
  • 4

  • Latest Deal Type
  • Out of Business

Venneos General Information


Developer of a silicon-chip-based imaging system designed to analyse biological cells. The company's imaging system helps in the label-free analysis of biological cells and to detect cellular changes which remain invisible with other technologies, enabling researchers to acquire information in areas such as tumor biology, immunology and pharmacology as well as in pharma and biotech companies.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Primary Office
  • Nobelstraße 15
  • 70569 Stuttgart
  • Germany
+49 0711 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Venneos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-May-2018 00.000 Completed Out of Business
3. Early Stage VC (Series A) 26-Sep-2017 00.000 Completed Generating Revenue
2. Seed Round 11-Sep-2015 $1.12M $1.12M Completed Startup
1. Grant 13-Jul-2015 $2.24K Completed Startup
To view Venneos’s complete valuation and funding history, request access »

Venneos Executive Team (4)

Name Title Board Seat Contact Info
Ralf Zeitler Co-Founder & Managing Director
Jonas Lehmann Co-Founder
Tu Hoang Ph.D Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

Venneos Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial